ADC Therapeutics (NYSE:ADCT) Q3 2026 Earnings Call
ADC Therapeutics (NYSE:ADCT) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Adc Therapeutics SA (NYSE:ADCT)
- Period
- Q3 2026 earnings call
- Date
- Mon, Nov 9, 2026, 8:30 AM ET
On 6ix: 6ix.com/event/adc-therapeutics-sa-adct-q3-2026-earnings-call
Latest news releases
- NYSE:ADCT — ADC Therapeutics Announces Abstracts at the 68th ASH Annual Meeting Highlighting Breadth of ZYNLONTA® Clinical Program · Wed, Nov 4, 2026
- NYSE:ADCT — ADC Therapeutics to Present at November Investor Conferences · Tue, Nov 3, 2026